Navigation Links
Disease Management Protocols at Lehigh Valley PPO, Valley Preferred, Making A Difference
Date:1/12/2010

ALLENTOWN, Pa., Jan. 12 /PRNewswire/ -- Physicians participating with Valley Preferred, a community-based preferred provider organization located in Allentown, Pennsylvania, are reducing usage of critical health care services by improving methods in which they manage disease -- and the results are notable. The results are based on managing populations of patients who have their health insurance coverage with a Valley Preferred payer partner.

"In today's world, we can lessen the dependence on health care," says Jack Lenhart, M.D., Valley Preferred's Medical Director. "There is an epidemic of increasing chronic disease, and better disease management and prevention are the best practices that yield the most positive results. Chronic diseases such as asthma, COPD (chronic obstructive pulmonary disease), congestive heart failure, diabetes, high cholesterol, hypertension and vascular disease must be actively targeted for prevention, and improved care by physicians and patients in order to combat the high costs of these diseases." Nationally, chronic diseases consume more than 70 percent of health care costs [Source: Institute of Medicine, www.iom.edu].

From 2006 to 2007, Valley Preferred reports reduced medical needs related to select chronic diseases as follows: a 25 percent decrease in hospital admissions; 44 percent decrease in hospital days; and a 33 percent decrease in emergency room visits. Equally important was the corresponding 6 percent decrease in the number of absences and 50 percent decrease in the number of days absent on the job.

Take diabetes control, for instance. T
'/>"/>

SOURCE Valley Preferred
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. deCODE Finds Genetic Factors Impacting Key Clinical Measurements of Heart Activity and Disease Risk
2. Sinovac Files Clinical Trial Application with SFDA for Vaccine Against Hand, Foot, and Mouth Disease
3. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
4. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
5. AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease
6. miRagen announces discovery of key microRNA implicated in Lou Gehrigs disease
7. Successful Stem Cell Therapy for Treatment of Eye Disease
8. Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years
9. Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner
10. Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimers Disease
11. Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... DIEGO, July 30, 2015   Senomyx , Inc. ... taste science technologies to discover, develop, and commercialize novel ... industries, today reported financial results for the second quarter ... of 2015, we remain on track to achieve our ... Chief Executive Officer of the Company. "Since our last ...
(Date:7/30/2015)... ST. LOUIS, July 30, 2015 ... period in 2014) , Reported sales were $697 ... of 2014.  Sales grew organically by 8%, and changes ... Recent acquisitions increased sales by 1%. , By ... 8% in Applied and 11% in SAFC Commercial. ...
(Date:7/30/2015)... ... July 30, 2015 , ... GEA's Pony™ ... for continuous operation up to 1500 bar. The sanitary design gauge of the ... toxic contamination. , The Pony™ NS2006L homogenizer is an ideal solution for the ...
(Date:7/29/2015)... BANGALORE , July 30, 2015 ... Cell Market - Growth, Trends & Forecasts (2015-2020), , published ... worth US$ 30.25 billion by the end of 2020, with ... globally accounting for more than 40% of the global market ... grow at a CAGR of 13.7% during the period of ...
Breaking Biology Technology:SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3
... . is now using radio frequency identification (RFID) software ... world's largest manufacturer of cordless telephones. , ,RFID mandates ... engage the supply chain management technology, according to Catalyst. ... passive RFID technology into its supply chain environment. ...
... few weeks away because I begin to sort and organize ... and working on opening remarks. I like to think that my ideas ... for sure is that at least once a year, my garage is ... ,This is also a journey of discovery -- like the original Rex ...
... also operating as Online-Kiosks.net, an online ... enables resellers and systems integrators to sell ... to customers without major investments in technology or ... digital signage solutions to their customers using standard ...
Cached Biology Technology:End of summer unearths new tech discoveries 2End of summer unearths new tech discoveries 3End of summer unearths new tech discoveries 4
(Date:7/2/2015)... June 25, 2015 ... addition of the "Natural Language Processing Market ... IVR, OCR, Pattern & Image Recognition) - Worldwide ... The key vendors occupying the market ... Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute Inc., ...
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
(Date:6/26/2015)... , June 26, 2015 ATL Technology, LLC, a ... with specialties in single use solutions, headquartered in ... Inc. (a California corporation with locations ... San Jose, Costa Rica ). This ... Rica with ATL Technology,s existing facility in ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... lineagefossilized tracksis described this week in Proceedings of ... million years after the massive Permian-Triassic extinction, an animal ... in what is now Poland. This fossilized trackway places ... 250 million years ago5 to 9 million years earlier ...
... seekingthe urge to do exciting thingshas been linked to dopamine, ... new study published in Psychological Science, a journal ... the dopamine system and found a group of mutations that ... Sensation seeking has been linked to a range of behavior ...
... University HealthSystem (NorthShore) have developed a method to detect ... in humans using pioneering biophotonics technology. "By ... technology, we have the potential to prescreen patients at ... smoke, and identify the individuals who would likely benefit ...
Cached Biology News:Oldest evidence of dinosaurs found in Polish footprints 2Oldest evidence of dinosaurs found in Polish footprints 3A thirst for excitement is hidden in your genes 2Early lung cancer detection 2Early lung cancer detection 3